Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


09.10.2017

1 Am J Epidemiol
1 Antimicrob Agents Chemother
1 J Infect
1 Lancet
10 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. MARTINEZ L, Shen Y, Mupere E, Kizza A, et al
    Transmission of Mycobacterium Tuberculosis in Households and the Community: A Systematic Review and Meta-Analysis.
    Am J Epidemiol. 2017;185:1327-1339.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  2. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    PubMed     Text format     Abstract available


    J Infect

  3. NOUHIN J, Pean P, Madec Y, Chevalier MF, et al
    Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
    J Infect. 2017;74:456-465.
    PubMed     Text format     Abstract available


    Lancet

  4. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


    PLoS One

  5. ELLIS CK, Rice S, Maurer D, Stahl R, et al
    Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.
    PLoS One. 2017;12:e0179914.
    PubMed     Text format     Abstract available

  6. MICHEL AL, Lane EP, de Klerk-Lorist LM, Hofmeyr M, et al
    Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology.
    PLoS One. 2017;12:e0179943.
    PubMed     Text format     Abstract available

  7. MAILANKODY S, Dangeti GV, Soundravally R, Joseph NM, et al
    Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    PLoS One. 2017;12:e0181262.
    PubMed     Text format     Abstract available

  8. THERON A, Roth RL, Hoppe H, Parkinson C, et al
    Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
    PLoS One. 2017;12:e0185068.
    PubMed     Text format     Abstract available

  9. WANG X, Jiang H, Wang X, Liu H, et al
    ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China.
    PLoS One. 2017;12:e0185646.
    PubMed     Text format     Abstract available

  10. BOIREAU C, Dufour B, Praud A
    The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France.
    PLoS One. 2017;12:e0185799.
    PubMed     Text format     Abstract available

  11. YU EA, John SH, Tablante EC, King CA, et al
    Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.
    PLoS One. 2017;12:e0185640.
    PubMed     Text format     Abstract available

  12. MEKONNEN E, Bekele E
    An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.
    PLoS One. 2017;12:e0184931.
    PubMed     Text format     Abstract available

  13. TYLER AD, Randell E, Baikie M, Antonation K, et al
    Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada.
    PLoS One. 2017;12:e0185656.
    PubMed     Text format     Abstract available

  14. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  15. BLANC L, Gilleron M, Prandi J, Song OR, et al
    Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.
    Proc Natl Acad Sci U S A. 2017 Oct 2. pii: 201707840.
    PubMed     Text format     Abstract available

  16. KOSTER S, Upadhyay S, Chandra P, Papavinasasundaram K, et al
    Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA.
    Proc Natl Acad Sci U S A. 2017 Sep 27. pii: 201707792.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: